• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NasdaqGS
    115.15 Up 1.40(1.23%) Dec 24, 1:00PM EST
    Add to Portfolio
    Prev Close:113.75
    Open:113.75
    Bid:N/A
    Ask:125.35 x 200
    1y Target Est:125.27
    Beta:-1.01
    Earnings Date:Jan 27 - Feb 2 (Est.)
    Day's Range:113.31 - 117.29
    52wk Range:59.79 - 124.35
    Volume:519,021
    Avg Vol (3m):1,704,110
    Market Cap:27.70B
    P/E (ttm):N/A
    EPS (ttm):-2.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VRTXUp 1.23%27.70B
    BMYDown 0.02%98.12B
    MRKUp 0.44%163.81B
    PTCTUp 1.49%1.52B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):34.76
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-3.04
    Quarterly EPS Est (Dec-14) :-0.67
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-1.99

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback